Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 26.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
26.02.Berkshire bleibt auf Erfolgskurs72Der Geschäftsbericht von Berkshire Hathaway wird jedes Frühjahr von mehr Anlegern erwartet als jeder andere. Denn neben den Unternehmenszahlen enthält er immer auch einen neuen der legendären "Briefe...
► Artikel lesen
26.02.Barsele Minerals Corp.: Barsele and Gold Line Complete Previously Announced Merger400VANCOUVER, BC AND TORONTO, Feb. 26, 2024 /CNW/ - Barsele Minerals Corp. ("Barsele") (TSXV: BME) and Gold Line Resources Ltd. ("Gold Line") (TSXV: GLDL) are pleased to announce, further to the news...
► Artikel lesen
26.02.Open-Source-Projektmanagement-Software: Die 5 besten Tools352Mit den richtigen Projektmanagement-Tools können Teams leichter ihre Ziele und Meilensteine erreichen, Fristen und Budgets einhalten und Projekte skalieren. In dieser Liste findest du die fünf am besten...
► Artikel lesen
26.02.Abschluss des Verfahrens zur DFL-Zentralvermarktung: Bundeskartellamt billigt Vermarktungsmodell der DFL165Das Bundeskartellamt hat das Verfahren zur Prüfung des Vermarktungsmodells der Deutsche Fußball Liga (DFL) für die Vergabe der Medienrechte an den Spielen der Bundesliga und der 2. Bundesliga ab der...
► Artikel lesen
26.02.APA Corporation Announces Timeline For Closing of Callon Petroleum Company Transaction; Issues Investor Slide Deck Highlighting Top-Tier Permian Performance202HOUSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- APA Corporation (NASDAQ: APA) announced today that the applicable statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976...
► Artikel lesen
26.02.Timbercreek Financial Announces 2023 Fourth Quarter Results and Special Dividend154TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the "Company") announced today its financial results for the three months and year ended December 31, 2023 ("Q4 2023")....
► Artikel lesen
26.02.Carlyle Secured Lending, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results, Increases Base Dividend to $0.40 Per Common Share and Declares First Quarter 2024 Dividends of $0.48 Per Common Share250NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CSL" or the "Company") (NASDAQ: CGBD) today announced its...
► Artikel lesen
26.02.Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2023 Results183- Acquired 75 USPS Properties for $20.7 Million in Fourth Quarter 2023 -- Net Income Attributable to Common Shareholders of $0.12 and Adjusted Funds from Operations of $1.07 Per Diluted Share for...
► Artikel lesen
26.02.Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement159PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, "Scilex" or "Company"), an innovative revenue-generating company focused on acquiring, developing and commercializing...
► Artikel lesen
26.02.Rogers Sugar Inc.: Rogers Sugar Announces a $110 Million Equity Offering to Fund a Portion of its Sugar Capacity Expansion Project250MONTREAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Montreal (Québec), February 26, 2024 - Rogers Sugar Inc. (the "Company" or...
► Artikel lesen
26.02.Day One Biopharmaceuticals, Inc.: Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress250PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023...
► Artikel lesen
26.02.Dorman Products, Inc. Reports Fourth Quarter and Full Year 2023 Results; Issues 2024 Guidance291Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $494.3 million for the quarter, down 1% reflecting the impact of an extra week in the prior year...
► Artikel lesen
26.02.Kite Realty Group Trust Upgraded by Moody's to Baa2 with Stable Outlook201INDIANAPOLIS, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today that Moody's Investors Service ("Moody's") upgraded the Company's corporate credit rating to Baa2...
► Artikel lesen
26.02.Lithium Americas (Argentina) Corp.: Lithium Argentina Announces Appointment of new President and CEO298VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) ("Lithium Argentina" or the "Company") announces the Board's unanimous decision...
► Artikel lesen
26.02.Sezzle Fourth-Quarter and Fiscal Year 2023 Results154Minneapolis, MN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, is pleased to provide the market with an update...
► Artikel lesen
26.02.SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance195SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
► Artikel lesen
26.02.FibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results499• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246 in metastatic castration-resistant prostate...
► Artikel lesen
26.02.Revolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress188REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers...
► Artikel lesen
26.02.PubMatic, Inc.: PubMatic Announces Record Fourth Quarter and Fiscal Year Ended 2023 Financial Results; Board of Directors Expands Share Repurchase Program by $100 Million234Q4 2023 revenue and adjusted EBITDA significantly exceeded guidance; Revenue growth accelerated to $84.6 million, up 14% over Q4 2022, delivered net income of $18.7 million or 22% margin, adjusted...
► Artikel lesen
26.02.Codexis, Inc.: Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche305REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive...
► Artikel lesen
Seite:  Weiter >>